CRC patients had elevated levels of CD33+CD11b+HLA-DR– MDSCs in primary tumor tissues and in peripheral blood. These elevated circulating MDSCs were correlated with advanced TNM stages and lymph node metastases. The gene discussed is CD33; the disease is neoplasm.